Trial Condition(s):

Premenstrual Syndrome, Contraceptives, Oral

Study to assess efficacy of a monophasic oral contraceptive preparation containing Drospirenone 3 mg/Ethinylestradiol 20 μg in the treatment of Premenstrual Dysphonic Disorder

Bayer Identifier:

91001

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
65
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
YAZ (EE20/DRSP, BAY86-5300)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design